In the five years to 2012, revenue for the DNA and DNA Forensic Laboratories industry grew robustly in the five years to 2012. The industry is composed of major companies like Orchid Cellmark and Laboratory Corporation. The industry has benefited from rapid technology improvements that have boosted efficiency, therefore increasing price-based competition. In the five years to 2017, revenue is expected to slow (as compared with the previous five years). The industry is marked by expansion, as firms open to take advantage of the industry's high profit margins. For these reasons, industry research firm IBISWorld has added a report on the DNA & DNA Forensic Laboratories industry to its growing industry report collection. <\/p>\n
Los Angeles, CA (PRWEB) November 08, 2012 <\/p>\n
High profit margins have caused the number of firms operating in the DNA and DNA Forensic Laboratories industry to increase marginally over the past five years. IBISWorld estimates that the number of industry enterprises has grown at an average rate of just 1.0% annually to 128 in the five years to 2012, Culbert says. In spite of the overall growth, the industry has experienced some consolidation during that time. For example, major player Lab Corp acquired Orchid Cellmark Inc, one of the industry's largest DNA testing companies in April 2011. <\/p>\n
IBISWorld estimates that industry revenue will increase in the five years to 2017. During that time, the industry is expected to continue to benefit from improved technology, which will increase productivity and revenue. Consistent investment in research and development has increased the throughput capacity of DNA laboratories, which has ultimately caused prices to decline. Although falling prices will limit profit margins on individual tests, an increase in the volume of DNA analysis performed, coupled with a decline in costs, will mitigate any associated declines with profit margins. Although the industry has high barriers to entry, the diverse nature of the products this industry offers keeps market concentration low. The top three firms are estimated to account for about one-fifth of the market. For more information, visit IBISWorlds DNA & DNA Forensic Laboratories in the US industry report page. <\/p>\n
Follow IBISWorld on Twitter: https:\/\/twitter.com\/#!\/IBISWorld<\/a> <\/p>\n Friend IBISWorld on Facebook: http:\/\/www.facebook.com\/pages\/IBISWorld\/121347533189<\/a> <\/p>\n IBISWorld industry Report Key Topics <\/p>\n This industry provides DNA paternity testing, DNA forensic services, veterinary DNA testing, ancestry tracking and other services related to human genetics. It excludes not-for-profit, state-funded and state-owned institutions such as public university labs, and labs that are owned and operated by law enforcement entities and the court system. Although some operators have multiple patient service centers, the industry is composed of the laboratories to which samples are submitted. <\/p>\n Industry Performance <\/p>\n Executive Summary <\/p>\n<\/p>\n Read more: In the five years to 2012, revenue for the DNA and DNA Forensic Laboratories industry grew robustly in the five years to 2012. The industry is composed of major companies like Orchid Cellmark and Laboratory Corporation. Continue reading
\nDNA & DNA Forensic Laboratories in the US Industry Market Research Report Now Available from IBISWorld<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"